Australia markets open in 3 hours 9 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
137.73-0.07 (-0.05%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
365,135
380,833
301,034
154,584
5,421
Cost of revenue
54,154
56,586
34,193
7,353
130
Gross profit
310,981
324,247
266,841
147,231
5,291
Operating expenses
Research development
657,215
560,909
401,843
166,707
188,272
Selling general and administrative
253,519
284,812
209,983
119,850
81,201
Total operating expenses
925,688
846,570
612,691
287,610
269,473
Operating income or loss
-614,707
-522,323
-345,850
-140,379
-264,182
Interest expense
29,528
30,669
33,709
5,781
-
Total other income/expenses net
16,341
-168,126
10,139
95,723
-2,548
Income before tax
-620,562
-713,880
-362,610
-48,628
-267,265
Income tax expense
-295
1,195
-692
2,060
-
Income from continuing operations
-620,267
-715,075
-361,918
-50,688
-267,265
Net income
-620,267
-715,075
-361,918
-50,688
-267,265
Net income available to common shareholders
-620,267
-715,075
-361,918
-50,688
-267,265
Basic EPS
-
-9.71
-5.46
-0.86
-5.49
Diluted EPS
-
-9.71
-5.46
-0.86
-5.49
Basic average shares
-
73,615
66,250
58,818
48,697
Diluted average shares
-
73,615
66,250
58,818
48,697
EBITDA
-
-652,664
-316,656
-34,755
-258,571